Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2025 ,inter alia, to consider and approve Please find enclosed.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has informed BSE and NSE that its Board of Directors will meet on Sunday, November 9, 2025 to consider and approve the Unaudited Financial Results (both standalone and consolidated) for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the auditors. The trading window for dealing in company securities is closed from October 1, 2025 until November 11, 2025. No financial numbers or detailed agenda items have been disclosed in this intimation.
This is a routine regulatory filing ahead of the Q2 FY26 earnings announcement. Investors should watch November 9 for the actual results, but no immediate impact on the stock price is expected from this notice alone.